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• Immunohistochemistry (IHC) was performed to assess whether
Transactive response Deoxyribonucleic acid binding Protein 43 (TDP-
43) liquid-liquid phase separation (LLPS) regulates lipopolysaccaride
(LPS)-induced neuroinflammation. Quantification and intensity results
of glia cells and cytokines indicate that TDP-43 LLPS does not likely
regulate LPS-induced neuroinflammation.
• TDP-43 is encoded by the TARDP gene and is a key player in
pathogenesis of neurodegenerative diseases such as Amyotrophic
Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Alzheimer’s
Disease (AD), and Inclusion Body Myositis. Neuroinflammation is a
pathological feature of neurodegenerative diseases and is
characterized by increases in glia cells and cytokines. TDP-43
proteinopathy has been found to increase the number of microglia
and astrocytes, and intensity of interleukin-1beta (IL-1β) and tumor
necrosis factor-alpha (TNF-α). Recently, research has been
performed in Dr. Xinglong Wang’s laboratory investigating the in vivo
physiological function TDP-43 LLPS in mice. LLPS of proteins
underlies the formation of membrane-less organelles and is
suspected to possibly play a role in disease. TDP-43 LLPS regulation
of neuroinflammation remains elusive and warrants further
investigation. LLPS function can be removed via deletion of the
conserved region (CR) of TDP-43. To investigate the relationship
between TDP-43 LLPS and neuroinflammation, IHC was performed to
assess the quantity of microglia and astrocytes and intensity of IL-
1beta and TNF-alpha in brain tissue of wild type (WT) and transgenic
(TDP-43ΔCR+/-) mice with and without LPS treatment. • TDP-43 LLPS did not show a significant difference in regulation of glia
cells or cytokines in LPS-induced neuroinflammation. Since three mice
were used for each group, this study could be replicated again in the
future with more mice for each group to generate better results. Future
studies may also investigate TDP-43 phase LLPS in different areas
locally or globally.
• Funding was provided by UNMC MD-PhD Scholars Program.
• Special thanks to Dr. Xinglong Wang and laboratory members for their


























































































































































Fig. 3 (A) Bar graph comparing GFAP quantification in the cortex for WT and TDP-43ΔCR+/- with and without LPS treatment, (B) cortex images of WT no LPS, TDP-43ΔCR+/- no LPS, WT with LPS, TDP-43ΔCR+/- with 
LPS, (C) Bar graph comparing GFAP quantification in the hippocampus for WT and TDP-43ΔCR+/- with and without LPS treatment, (D) hippocampus images of WT no LPS, TDP-43ΔCR+/- no LPS, WT with LPS, TDP-
43ΔCR+/- with LPS. * indicates p < 0.05
Fig. 4 (A) Bar graph comparing IBA1 quantification in the cortex for WT and TDP-43ΔCR+/- with and without LPS treatment, (B) cortex images of WT no LPS, TDP-43ΔCR+/- no LPS, WT with LPS, TDP-43ΔCR+/-
with LPS, (C) Bar graph comparing IBA1 quantification in the hippocampus for WT and TDP-43ΔCR+/- with and without LPS treatment, (D) hippocampus images of WT no LPS, TDP-43ΔCR+/- no LPS, WT with 
LPS, TDP-43ΔCR+/- with LPS. 
Fig. 5 (A) Bar graph comparing IL-1β quantification in the cortex for WT and TDP-43ΔCR+/- with and without LPS treatment, (B) cortex images of WT no LPS, TDP-43ΔCR+/- no LPS, WT with LPS, TDP-43ΔCR+/- with 
LPS, (C) Bar graph comparing IL-1β quantification in the hippocampus for WT and TDP-43ΔCR+/- with and without LPS treatment, (D) hippocampus images of WT no LPS, TDP-43ΔCR+/- no LPS, WT with LPS, TDP-
43ΔCR+/- with LPS. * indicates p < 0.05
Fig. 6 (A) Bar graph comparing TNF-α quantification in the cortex for WT and TDP-43ΔCR+/- with and without LPS treatment, (B) cortex images of WT no LPS, TDP-43ΔCR+/- no LPS, WT with LPS, TDP-43ΔCR+/-
with LPS, (C) Bar graph comparing TNF-α quantification in the hippocampus for WT and TDP-43ΔCR+/- with and without LPS treatment, (D) hippocampus images of WT no LPS, TDP-43ΔCR+/- no LPS, WT with LPS, 
TDP-43ΔCR+/- with LPS. * indicates p < 0.05
Scan QR code for detailed IHC protocol.
Fig. 1 Domains of TDP-43. CR located in the low complexity domain in red.
Fig. 2 Schematic of TDP-43 LLPS via the CR.
1. No significant difference in number of astrocytes between WT and 
TDP-43ΔCR+/- with and without LPS treatment.
2. No significant difference in number of microglia between WT and 
TDP-43ΔCR+/- with or without LPS treatment.
3. No significant difference in intensity of IL-1β between WT and TDP-
43ΔCR+/- with or without LPS treatment.
4. No significant difference in intensity of TNF-α between WT and 
TDP-43ΔCR+/- with or without LPS treatment.
Fig. 7 Schematic of IHC.
• Peroxidase Anti-Peroxidase IHC
• Sectioning via microtome
• Incubation
• Deparaffinization/rehydration
• Antigen retrieval via pressure 
cooker
• Application of primary and 

























GFAP Quantification in the Cortex
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